A new government-run discount medicine website is set to launch this month. It's called TrumpRx: A direct-to-consumer drug ...

Without greed, we wouldn’t have many of the benefits we enjoy today, such as cars, heated homes and computers, argue our ...

Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...

WELCOME TO 2026: As the capital jolts back to life after a much-needed break, the city’s lobbyist class is preparing for a ...

The Singapore-based AI clinical trial engine powering Asia’s—especially China’s—rapid rise in the biotech industry.Deep ...

Optimism for AI-powered drug discovery is rising as industry giants, startups, and even Sam Altman step up investments ...

Pharmaceutical companies are getting a fresh look for a range of drugs in development, plus a regulatory reprieve.

We’ve seen the first AI-generated commercials, songs and even social media influencers outside of healthcare. Will pharma be ...

Vertex Pharmaceuticals (VRTX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

India's Torrent Pharmaceuticals is set to raise up to 125 billion rupees ($1.4 billion) through short-duration bond sales in January, in one of the latest acquisition-funding deals, two bankers said.

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $469.68, marking a -2.99% move from the previous day. This change lagged the S&P 500's daily gain of 0.01%. On the other hand, ...

NDT Pharmaceuticals’ Wholly Owned Subsidiary Good Salt Life, Inc. Advances Toward Key Regulatory Milestones for Clean ...